Aurora Cannabis (TSE:ACB) Hits New 52-Week High at $9.59

Aurora Cannabis Inc. (TSE:ACBGet Free Report) reached a new 52-week high during trading on Wednesday . The stock traded as high as C$9.59 and last traded at C$9.12, with a volume of 3521393 shares. The stock had previously closed at C$6.78.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. CIBC lowered their price objective on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price objective on the stock in a report on Friday, February 9th. Finally, Jefferies Financial Group cut their price objective on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th.

Get Our Latest Stock Analysis on ACB

Aurora Cannabis Price Performance

The company has a debt-to-equity ratio of 18.51, a current ratio of 3.79 and a quick ratio of 2.48. The business’s fifty day moving average price is C$3.20 and its 200-day moving average price is C$1.57. The stock has a market capitalization of C$531.77 million, a price-to-earnings ratio of -0.10 and a beta of 2.83.

Aurora Cannabis (TSE:ACBGet Free Report) last announced its quarterly earnings results on Thursday, February 8th. The company reported C($0.20) earnings per share for the quarter, missing the consensus estimate of C($0.10) by C($0.10). The business had revenue of C$72.61 million during the quarter, compared to the consensus estimate of C$63.50 million. Aurora Cannabis had a net margin of 151.71% and a negative return on equity of 137.28%. On average, research analysts forecast that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

See Also

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.